>

Galapagos Stock News Today

<div class='circular--portrait' style='background:#FCD202;color: white;font-size:4em;padding-top: 25px;;'>GA</div>
GLPG -- USA Stock  

Earning Report: 24th of April 2020  

Galapagos Stock News module provides quick insight into current market opportunities from investing in Galapagos NV. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Galapagos NV stock news signals to limit their universe of possible portfolio assets and to time the market correctly. Please check Galapagos Hype Analysis, Galapagos Correlation and Galapagos Performance.
View Today's Stock News For
Refresh
Galapagos stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Galapagos daily returns and investor perception about the current pice of Galapagos NV as well as its diversification or hedging effects on your existing portfolios.
  
over two weeks ago at uspostnews.com         
Stocks That Are Finally Turning The Corner Galapagos NV , Canadian Solar - US Post News
USpostnews News at Macroaxis
NV , Canadian Solar US Post News
  
  
over three weeks ago at finance.yahoo.com         
Hedge Funds Were Buying Galapagos NV Before The Coronavirus - Yahoo Finance
Yahoo News
NV Before The Coronavirus Yahoo Finance
  
  
over three weeks ago at www.nasdaq.com         
GLPG Crosses Below Key Moving Average Level - Nasdaq
nasdaq News
GLPG Crosses Below Key Moving Average Level Nasdaq
  
  
over a month ago at www.wsj.com         
Gilead Sciences to Buy Forty Seven for 4.9 Billion - The Wall Street Journal
wsj  News
Gilead Sciences to Buy Forty Seven for 4.9 Billion The Wall Street Journal
  
  
over a month ago at seekingalpha.com         
Galapagos Ratings Downgrade, And Other News The Good, Bad And Ugly Of Biopharma - Seeking Alpha
seekingalpha News
Ratings Downgrade, And Other News The Good, Bad And Ugly Of Biopharma Seeking Alpha
  
  
over a month ago at www.streetinsider.com         
Galapagos NV PT Raised to 298 at Stifel - StreetInsider.com
Street Insider News
NV PT Raised to 298 at Stifel StreetInsider.com
  
  
over a month ago at www.nasdaq.com         
Health Care Sector Update for 02212020 GLPG,EHTH,SEM,EYPT - Nasdaq
nasdaq News
Health Care Sector Update for 02212020 GLPG,EHTH,SEM,EYPT Nasdaq
  
  
over a month ago at www.globenewswire.com         
Transformational year for Galapagos Brussels Stock ExchangeGLPG - GlobeNewswire
news
Brussels Stock ExchangeGLPG GlobeNewswire
  
  
over a month ago at www.gurufocus.com         
Feb 18, 2020 - Profund Advisors Llc Buys Intel Corp, NVIDIA Corp, Broadcom Inc, Sells Celgene Corp, ...
news
Feb 18, 2020 - Profund Advisors Llc Buys Intel Corp, NVIDIA Corp, Broadcom Inc, Sells Celgene Corp, American Tower Corp, TripAdvisor Inc GuruFocus.com
  
  
over two months ago at slatersentinel.com         
Brokerages Anticipate GALAPAGOS NVS Will Post Quarterly Sales of 236.03 Million - Slater Sentinel
news
Brokerages Anticipate GALAPAGOS NVS Will Post Quarterly Sales of 236.03 Million Slater Sentinel
  
  
over two months ago at seekingalpha.com         
Gileads Revenues Stabilize, Supporting Its Outlook - Seeking Alpha
seekingalpha News
Gileads Revenues Stabilize, Supporting Its Outlook Seeking Alpha
  
  
over two months ago at www.sharecast.com         
Europe close Stocks finish at session highs despite virus fears - ShareCast
news
Europe close Stocks finish at session highs despite virus fears ShareCast
  
  
over two months ago at www.fool.com         
Better Buy Intercept Pharmaceuticals vs. Gilead Sciences - Motley Fool
fool News
Better Buy Intercept Pharmaceuticals vs. Gilead Sciences Motley Fool
  
  
over two months ago at www.globenewswire.com         
Orphan Drug Designation for GLPG1690 in systemic sclerosis - GlobeNewswire
news
Orphan Drug Designation for GLPG1690 in systemic sclerosis GlobeNewswire
  
  
over two months ago at www.fool.com         
Better Buy Vertex Pharmaceuticals vs. Galapagos - The Motley Fool
fool News
The Motley Fool
  

Galapagos Performance against DOW

 Price Growth (%)  
    
  Timeline 
1
GALAPAGOS NVS Downgraded by JPMorgan Chase Co. to Neutral - ...01/21/2020
2
Unclassified Event01/27/2020
3
Better Buy Intercept Pharmaceuticals vs. Gilead Sciences - M...01/30/2020
4
Unclassified Event02/14/2020
5
Health Care Sector Update for 02212020 GLPG,EHTH,SEM,EYPT - ...02/21/2020
6
Gilead Sciences to Buy Forty Seven for 4.9 Billion - The Wal...03/02/2020
7
Stocks That Are Finally Turning The Corner Galapagos NV , Ca...03/18/2020
Please check Galapagos Hype Analysis, Galapagos Correlation and Galapagos Performance. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page